Sort   by:  
 Page size 
UnknownGenetic analysis and natural history of Parkinson's disease due to the LRRK2 G2019S variant.
Not available
S-EPMC11146432 | biostudies-literature
UnknownSafety and Activity of Mirvetuximab Soravtansine (IMGN853), a Folate Receptor Alpha-Targeting Antibody-Drug Conjugate, in Platinum-Resistant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer: A Phase I Expansion Study.
Not available
S-EPMC5559878 | biostudies-literature
UnknownDisease activity, cytokines, chemokines and the risk of incident diabetes in rheumatoid arthritis.
Not available
S-EPMC8928597 | biostudies-literature
UnknownPerformance of an Idiopathic Pulmonary Fibrosis-Derived Multibiomarker Panel for Rheumatoid Arthritis-Associated Interstitial Lung Disease.
Not available
S-EPMC12936895 | biostudies-literature
UnknownPlasma Matrix Metalloproteinase Concentrations and Risk of Interstitial Lung Disease in a Prospective Rheumatoid Arthritis Cohort.
Not available
S-EPMC11213673 | biostudies-literature
UnknownAntibodies to Malondialdehyde-Acetaldehyde Adduct Are Associated With Prevalent and Incident Rheumatoid Arthritis-Associated Interstitial Lung Disease in US Veterans.
Not available
S-EPMC11349468 | biostudies-literature
UnknownRandomized phase II trial of Onartuzumab in combination with erlotinib in patients with advanced non-small-cell lung cancer.
Not available
S-EPMC4878106 | biostudies-literature
UnknownPeripheral Biomarker Signatures in Rheumatoid Arthritis-Associated Interstitial Lung Disease.
Not available
S-EPMC12311258 | biostudies-literature
UnknownGenomewide Association Studies of LRRK2 Modifiers of Parkinson's Disease.
Not available
S-EPMC8252519 | biostudies-literature
UnknownThe effect of LRRK2 loss-of-function variants in humans.
Not available
S-EPMC7303015 | biostudies-literature
Sort   by:  
 Page size